Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lacasse

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Oncogene|September 21, 2004
Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeuticsDan C McManus, Charles A Lefebvre, Gabriele Cherton-Horvat, et al.
Oncogene|June 27, 2006
Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cellsZ Liu, H Li, X Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2008
Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activationD J Mahoney, H H Cheung, R Lejmi Mrad, et al.
Oncotarget|December 15, 2016
Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine modelChristine C Dobson, Thet Naing, Shawn T Beug, et al.
Frontiers in Immunology|May 4, 2023
LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signalingArya Afsahi, Christopher M Silvestri, Allyson E Moore, et al.
Plos One|March 9, 2018
Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarizationVirginia Morón-Calvente, Salvador Romero-Pinedo, Sofía Toribio-Castelló, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosisEric C LaCasse, Gabriele G Cherton-Horvat, Kimberley E Hewitt, et al.
Blood|October 9, 1999
Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantationE C LaCasse, M R Bray, B Patterson, et al.
Nature Communications|February 16, 2017
Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastomaShawn T Beug, Caroline E Beauregard, Cristin Healy, et al.
Nature Biotechnology|January 28, 2014
Smac mimetics and innate immune stimuli synergize to promote tumor deathShawn T Beug, Vera A Tang, Eric C LaCasse, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Oncogene|September 21, 2004
Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeuticsDan C McManus, Charles A Lefebvre, Gabriele Cherton-Horvat, et al.
Oncogene|June 27, 2006
Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cellsZ Liu, H Li, X Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2008
Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activationD J Mahoney, H H Cheung, R Lejmi Mrad, et al.
Oncotarget|December 15, 2016
Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine modelChristine C Dobson, Thet Naing, Shawn T Beug, et al.
Frontiers in Immunology|May 4, 2023
LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signalingArya Afsahi, Christopher M Silvestri, Allyson E Moore, et al.
Plos One|March 9, 2018
Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarizationVirginia Morón-Calvente, Salvador Romero-Pinedo, Sofía Toribio-Castelló, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosisEric C LaCasse, Gabriele G Cherton-Horvat, Kimberley E Hewitt, et al.
Blood|October 9, 1999
Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantationE C LaCasse, M R Bray, B Patterson, et al.
Nature Communications|February 16, 2017
Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastomaShawn T Beug, Caroline E Beauregard, Cristin Healy, et al.
Nature Biotechnology|January 28, 2014
Smac mimetics and innate immune stimuli synergize to promote tumor deathShawn T Beug, Vera A Tang, Eric C LaCasse, et al.
Pageof 7